Show Notes
KiwiSaver has grown to be worth more than $90 billion but much of that money is invested in foreign companies.
The reason for that is diversification. As investors we don't want all our eggs in one basket - investing all of our money in New Zealand would leave us highly exposed to our small country and its fortunes.
But David McLeish, head of fixed interest at Fisher Funds, believes the money that is being invested in New Zealand could be put to better use to support and grow New Zealand Inc.
He joins host Tamsyn Parker to discuss his recent opinion piece on the topic. See omnystudio.com/listener for privacy information.
More from Continuous Disclosure
It's time for another wrap of the markets - August saw many New Zealand companies report their earnings, with interesting insights into the state of the economy, while overseas, there is one thing that has investors and analysts interested and that is Ozempic! For this last episode of the season, Madison is joined by Fisher Funds Senior Portfolio Manager Sam Dickie to analyse the global markets.
It’s official - New Zealand was in a period of technical recession at the beginning of this year, according to GDP figures out this month.
There have not been any new companies listed on the NZX since December last year - so why is there such a dearth of companies publicly listing, and is there anything we can do to change that case?
The cost of medicine is always controversial, particularly in an election year. We’ve already seen the Government scrap prescription fees to make them more accessible – but what sort of costs really go in to making and licensing medicine, and how does being publicly listed impact a drugs company?
Over the last few weeks, Auckland Mayor Wayne Brown has attempted to get councillors on side with his desire to sell the council’s shares in Auckland Airport.